Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.3
Impact Factor 2024
1.5
CiteScore 2024
1.3
Impact Factor 2024
1.5
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Real-world experience with vismodegib and sonidegib in advanced basal cell carcinoma: a multicenter Italian study

    Mario Valenti, Sara Di Giulio, Andrea Carugno, Pasquale Frascione, Angelo Valerio Marzano, Santo Raffaele Mercuri, Gianluca Nazzaro, Giulia Spallone, Giovanni Paolino, Marco Ardigò
    18-02-2025
    https://doi.org/10.4081/dr.2025.10196
    562
    PDF: 478
    HTML: 12
  • Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

    Aikaterini Kyriakou, Anastasia Trigoni, Nikiforos Galanis, Dimitrios Sotiriadis, Aikaterini Patsatsi
    01-10-2018
    https://doi.org/10.4081/dr.2018.7859
    1973
    PDF: 1055
    HTML: 63
  • Treatment of periocular advanced basal cell carcinoma with Hedgehog pathway inhibitors: A single-center study and a new dedicated therapeutic protocol

    Vincenzo De Giorgi, Luciana Trane, Giulia Pieretti, Nicola Santoro, Flavia Silvestri , Federico Venturi, Federica Scarfi, Vincenza Maio, Giuseppe Spinelli, Silvia Scoccianti, Laura Guerrini, Daniela Massi, Cinzia Mazzini, Laura Doni
    05-08-2021
    https://doi.org/10.4081/dr.2021.9240
    3352
    PDF: 700
    HTML: 11
  • Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

    Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
    12-11-2024
    https://doi.org/10.4081/dr.2024.10080
    1157
    PDF: 655
    HTML: 27
  • Rilzabrutinib-induced transition from pemphigus vulgaris to pemphigus foliaceous: a case report and literature review

    Christian Ciolfi, Jacopo Tartaglia, Francesca Pampaloni, Laura Fagotto, Andrea Sechi, Mauro Alaibac
    23-10-2024
    https://doi.org/10.4081/dr.2024.10010
    600
    PDF: 350
    SUPPLEMENTARY MATERIAL: 152
    HTML: 14
  • Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

    Edoardo Mortato, Silvia Baratta, Luca Rubino, Anna Paola De Caro, Francesco Loconsole
    19-06-2023
    https://doi.org/10.4081/dr.2023.9755
    850
    PDF: 414
    HTML: 17
  • Environmental factors in autoimmune bullous diseases with a focus on seasonality: new insights

    Roberto D'Astolto, Lavinia Quintarelli, Alberto Corrà, Marzia Caproni, Luca Fania, Giovanni Di Zenzo, Biagio Didona, Giulia Gasparini, Emanuele Cozzani, Claudio Feliciani
    14-06-2023
    https://doi.org/10.4081/dr.2023.9641
    990
    PDF: 485
    HTML: 22
  • The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review

    Elena Pezzolo, Sara Di Leo, Paola Miceli, Alvise Sernicola, Luigi Naldi
    01-07-2025
    https://doi.org/10.4081/dr.2025.10112
    755
    PDF: 552
    HTML: 20
  • Efficacy of autologous serum therapy in positive and negative autologous serum skin test patients in chronic urticaria in a tertiary care centre

    Raghavendra KR, Bangaru H
    06-07-2022
    https://doi.org/10.4081/dr.2022.9525
    2133
    PDF: 536
    HTML: 62
  • New therapeutic applications of ozenoxacin in superficial skin infections

    Gema García Ron, María Villa Arranz
    05-08-2021
    https://doi.org/10.4081/dr.2021.9289
    2798
    PDF: 907
    Supplementary Files: 435
    HTML: 10
  • Therapeutic management of a symptomatic Kaposi’s sarcoma patient with renal failure undergoing haemodialysis: A case report

    Anna Passarelli, Giovanna Galdo, Teresa Pellegrino, Giandomenico Roviello, Michele Aieta, Gabriella Aviello, Raffaele Conca
    29-10-2021
    https://doi.org/10.4081/dr.2022.9113
    2522
    PDF: 642
    HTML: 17
  • Lichenoid dermatitis induced by abemaciclib in a patient with HR+/HER2– breast cancer

    Edoardo Mortato, Anna Paola De Caro, Luca Schinzari, Sonia Maniglio, Carmelo Laface, Gerardo Cazzato, Caterina Foti, Francesca Ambrogio
    19-11-2024
    https://doi.org/10.4081/dr.2024.10144
    595
    PDF: 381
    HTML: 30
  • Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

    Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota
    11-11-2024
    https://doi.org/10.4081/dr.2024.10140
    986
    PDF: 521
    SUPPLEMENTARY MATERIAL: 152
    HTML: 15
  • Rosacea-like eruptions associated with upadacitinib in atopic dermatitis: two case reports and management strategies

    Claudia Paganini, Edoardo Mortato, Lorenzo Tofani, Alfredo Belcastro, Marina Talamonti, Cosimo Di Raimondo, Luca Bianchi, Marco Galluzzo
    04-03-2025
    https://doi.org/10.4081/dr.2025.10193
    737
    PDF: 530
    HTML: 4
  • Severe and delayed-onset acneiform eruptions as an adverse reaction to regorafenib

    Haruhiko Otsuka, Takeshi Fukumoto, Naomi Kiyota, Chihiro Takemori, Haruki Jimbo, Chikako Nishigori
    01-01-2022
    https://doi.org/10.4081/dr.2022.9303
    1658
    PDF: 615
    HTML: 12
  • Attitudes among dermatologists regarding actinic keratosis treatment options

    Gaia Moretta, Tonia Samela, Francesca Sampogna, Francesco Ricci, Fabio Carlesimo, Annarita Panebianco, Angelo Massimiliano D’Erme, Giovanni Di Lella, Sabatino Pallotta, Elena Dellambra, Damiano Abeni, Luca Fania
    31-01-2022
    https://doi.org/10.4081/dr.2022.9392
    1078
    PDF: 662
    HTML: 12
  • Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

    Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly
    21-11-2022
    https://doi.org/10.4081/dr.2022.9265
    1530
    PDF: 450
    HTML: 27
  • Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

    Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza
    21-11-2022
    https://doi.org/10.4081/dr.2022.9447
    1306
    PDF: 405
    HTML: 45
  • Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

    Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło
    22-05-2023
    https://doi.org/10.4081/dr.2023.9630
    1057
    PDF: 563
    HTML: 73
  • Late reaction to ustekinumab infusion

    Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho
    e2
    09-09-2013
    https://doi.org/10.4081/dr.2013.e2
    3962
    PDF: 668
    HTML: 263
  • Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

    Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
    19-05-2023
    https://doi.org/10.4081/dr.2023.9692
    1056
    PDF: 546
    HTML: 19
  • Metastatic basal cell carcinoma to the bone: a case of bone metastasis in uncommon sites

    Olga Nigro, Claudio Chini, Ilaria Gioia Angiola Marcon, Annamaria De Giorgi, Linda Bascialla, Elisa Gallerani, Alice Giaquinto, Diego De Palma, Maurizio Lombardo
    12-07-2022
    https://doi.org/10.4081/dr.2022.9267
    1038
    PDF: 502
    Supplementary Table: 227
    HTML: 13
  • Rituximab for linear immunoglobulin A bullous dermatosis

    Rummit Dhillon, Lily Park, Sarah Gabros, Tam Nguyen, Stanley Skopit
    29-12-2022
    https://doi.org/10.4081/dr.2023.9574
    1353
    PDF: 558
    HTML: 32
  • A bibliometric study of the top 100 most cited articles on melanoma: insights into research trends and characteristics

    Jinhao Zhang, Xiangze Meng, Yun Wang, Wei Liu
    18-08-2025
    https://doi.org/10.4081/dr.2025.10435
    385
    PDF: 196
    SUPPLEMENTARY MATERIAL: 125
  • Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs

    Catharina Margrethe Lerche, Hans Christian Wulf
    e13
    14-09-2010
    https://doi.org/10.4081/dr.2010.e13
    2144
    PDF: 853
    HTML: 174
26 - 50 of 92 items << < 1 2 3 4 > >> 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • XXXI Congresso Nazionale Intergruppo Melanoma Italiano (IMI)
    • IMI - Epidemiology, genetics and pathogenesis
    • IMI - Prevention and diagnosis
    • IMI - Pathological and molecular classification
    • IMI - Surgery
    • IMI - Therapy
    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy